Currently out of the existing stock ratings of Conor Mcnamara, 149 are a BUY (84.18%), 28 are a HOLD (15.82%).

Conor Mcnamara

Work Performance Price Targets & Ratings Chart

Analyst Conor Mcnamara, carries an average stock price target met ratio of 46.36% that have a potential upside of 39.69% achieved within 311 days. Previously, Conor Mcnamara worked at RBC.

Conor Mcnamara’s has documented 351 price targets and ratings displayed on 14 stocks. The coverage was on Basic Materials, Healthcare sectors.

Most recent stock forecast was given on AVTR, Avantor at 03-Sep-2025.

Wall Street Analyst Conor Mcnamara

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 9/3/2025. The price target of $50 was fulfilled within 1 day with a profit of $0.73 (1.48%) receiving and performance score of 14.82.

Average potential price target upside

AVTR Avantor BIO Bio-Rad Laboratories DHR Danaher EXAS EXACT Sciences HOLX Hologic ILMN Illumina MRVI Maravai Lifesciences Holdings NTRA Natera OABI OmniAb QDEL Quidel RGEN Repligen SOPH Sophia Genetics SA TECH Bio-Techne Corp TMO Thermo Fisher Scientific

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Aug-2025

$16

$0.75 (4.92%)

$9

23 days ago
(09-Sep-2026)

9/13 (69.23%)

$1.12 (7.53%)

132

Hold Since 04-Aug-2025

$15

$-0.25 (-1.64%)

$12

2 months 2 days ago
(30-Jul-2026)

9/13 (69.23%)

$1.14 (8.23%)

53

Buy Since 11-Jun-2019

$16

$0.75 (4.92%)

$14

2 months 2 days ago
(30-Jul-2026)

4/10 (40%)

$2.14 (15.44%)

206

Hold Since 06-Apr-2026

$14

$-1.25 (-8.20%)

$10.5

2 months 2 days ago
(30-Jul-2026)

11/16 (68.75%)

$0.14 (1.01%)

39

Hold Since 04-Mar-2025

$11

$-4.25 (-27.87%)

$9

2 months 24 days ago
(08-Jul-2026)

14/23 (60.87%)

$1.24 (12.70%)

101

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?